Carnelian Capital Compounder Strategy
Snapshot & Key Metrics
Investment Objective
To generate superior risk-adjusted returns by investing in quality growth companies at reasonable valuations, combining accelerated growth and sustainable growth opportunities across sectors.
Core Highlights
Performance & Risk Metrics
| Period | Carnelian | BSE | Alpha |
|---|---|---|---|
| 1M | 4.6% | -0.1% | +4.7% |
| 3M | 12.1% | 3.9% | +8.2% |
| 6M | 15.8% | 1.4% | +14.3% |
| 1Yr | 22.4% | 4.7% | +17.6% |
| 2Yrs | 13.5% | -0.1% | +13.6% |
| 3Yrs | 23.8% | 12.1% | +11.8% |
| 5Yrs | 17.5% | 10.9% | +6.6% |
| Since Inception Absolute | 280.3% | 175.0% | +105.3% |
| Since Inception TWRR | 20.1% | 14.9% | +5.2% |
As of 31-08-2026, the strategy delivered 280.3% absolute return since inception and 20.1% annualised TWRR since inception, compared with 175.0% absolute return and 14.9% TWRR for BSE 500 TRI. Returns above one year are annualised. Actual performance may vary across investors.
Portfolio Composition
- Aditya Birla Capital9.5%
- Laurus Labs8.2%
- Biocon7%
- ONE 97 Communications5.4%
- BHEL4.2%
- Yatharth Hospital4.1%
- Star Health3.8%
- Pharma & CDMO29.3%
- BFSI - Credit15.5%
- BFSI - Non Credit11.8%
- Consumption9.5%
- Engineering & Capital Goods9.2%
- IT9%
- Auto & Auto Ancillary6.4%
Fund Manager Profile
Vikas Khemani
· FounderVikas Khemani brings over two decades of capital market stewardship, specializing in forensic financial statement analysis, disciplined risk sizing, and high-conviction equity portfolios.
View Fund House Team & CredentialsPhilosophy & Process
Quality Growth at a Reasonable Price (QGARP), combining accelerated growth and sustainable growth companies.
Evaluate sustainable business models, management quality, governance and opportunity size.
Identify accelerated growth (Magic) and sustainable growth (Compounder) companies.
Apply the proprietary CLEAR framework to assess cash flows, liabilities, earnings quality, asset quality and related-party and governance issues.
Build a diversified 25-30 stock multi-cap portfolio across identified investment opportunities.
Assess business, valuation, leverage and portfolio-level risks.
Investors seeking long-term exposure to Indian equities through a diversified multi-cap PMS strategy and who understand the risks of equity market investments.
- Investors with a long-term investment horizon
- Investors seeking diversified multi-cap equity exposure
- Investors comfortable with market volatility
- Investors seeking a quality growth-oriented investment approach
- Investors who understand PMS risks and have appropriate risk tolerance
Official Documents & Factsheets
Discuss Carnelian Capital Compounder Strategy With Our Senior Advisor
Have questions about allocation suitability, historical drawdown protection, fee structures, or onboarding formalities? Get in touch for an objective consultation.